Update README.md
Browse files
README.md
CHANGED
|
@@ -75,8 +75,7 @@ inaccurate metric values and hinder head-to-head comparisons between different m
|
|
| 75 |
|
| 76 |
### Performance
|
| 77 |
|
| 78 |
-
The antibody/nanobody-antigen data was curated from recently released PDBs,
|
| 79 |
-
specifically those released after September 30, 2021.
|
| 80 |
We also assessed the quality of the selected structures to ensure the interfaces are valid.
|
| 81 |
For instance, the binding sites are typically located in the complementarity-determining regions (CDRs) for
|
| 82 |
antibody-antigen or nanobody-antigen complexes.
|
|
|
|
| 75 |
|
| 76 |
### Performance
|
| 77 |
|
| 78 |
+
The antibody/nanobody-antigen data used for the evaluation was curated from recently released PDBs after September 30, 2021.
|
|
|
|
| 79 |
We also assessed the quality of the selected structures to ensure the interfaces are valid.
|
| 80 |
For instance, the binding sites are typically located in the complementarity-determining regions (CDRs) for
|
| 81 |
antibody-antigen or nanobody-antigen complexes.
|